Certara (CERT) announced a new collaboration with Merck (MRK) that expands Merck’s use of the Certara Pinnacle 21 software platform to include a metadata repository and data standards workflow management. This agreement builds upon Merck’s existing technology collaboration with Certara to aid in regulatory submissions. The Certara Pinnacle 21 platform is designed to solve the data standardization challenges of modern digital trials at scale.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CERT:
- Certara assumed with an Equal Weight at Morgan Stanley
- Certara’s Steady Growth Amid Strategic and Regulatory Uncertainties: A Hold Rating Analysis
- Schrodinger appoints Mannix Aklian as chief commercial officer
- Certara Holds Annual Stockholders Meeting on May 21
- Certara’s Stable Outlook: Hold Rating Maintained Amid Strategic and Financial Consistency